Naomi Eichenbaum | Vice President, Investor Relations |
Eric Dube | President and Chief Executive Officer |
Jula Inrig | Chief Medical Officer |
Peter Heerma | Chief Commercial Officer |
Chris Cline | Chief Financial Officer |
William Rote | Senior Vice President of Research and Development |
Maurice Raycroft | Jefferies |
Greg Harrison | Bank of America |
Tim Lugo | William Blair |
Liisa Bayko | Evercore ISI |
Laura Chico | Wedbush Securities |
Ed Arce | H.C. Wainwright & Co. |
Good day and welcome to the Travere Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call. Today's conference call is being recorded. At this time, I would like to turn the conference call over to the Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi.
Thank you, Carrie.